Jubilant Pharmova Limited (NSE:JUBLPHARMA) — Market Cap & Net Worth

$1.59 Billion USD · Rs146.75 Billion INR · Rank #7149

Market Cap & Net Worth: Jubilant Pharmova Limited (JUBLPHARMA)

Jubilant Pharmova Limited (NSE:JUBLPHARMA) has a market capitalization of $1.59 Billion (Rs146.75 Billion) as of May 2, 2026. Listed on the NSE stock exchange, this India-based company holds position #7149 globally and #326 in its home market, demonstrating a -0.15% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jubilant Pharmova Limited's stock price Rs926.60 by its total outstanding shares 158369748 (158.37 Million). Analyse JUBLPHARMA operating cash flow to see how efficiently the company converts income to cash.

Jubilant Pharmova Limited Market Cap History: 2015 to 2026

Jubilant Pharmova Limited's market capitalization history from 2015 to 2026. Data shows growth from $564.62 Million to $1.59 Billion (10.88% CAGR).

Index Memberships

Jubilant Pharmova Limited is a constituent of 5 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.11 Trillion	0.05%	#282 of 500
NIFTY ALHPA 50 NIFTYALI	$341.59 Billion	0.46%	#24 of 47
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.14%	#197 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.05%	#287 of 750
NIFTY SMALLCAP 250 NISM250	$375.15 Billion	0.42%	#97 of 250

Weight: Jubilant Pharmova Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Jubilant Pharmova Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Jubilant Pharmova Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.03x

Jubilant Pharmova Limited's market cap is 0.03 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.22x

Jubilant Pharmova Limited's market cap is 0.22 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$865.76 Million	$57.49 Billion	$3.92 Billion	0.02x	0.22x
2017	$1.09 Billion	$58.61 Billion	$5.76 Billion	0.02x	0.19x
2018	$988.90 Million	$75.18 Billion	$6.43 Billion	0.01x	0.15x
2019	$756.99 Million	$91.11 Billion	$5.74 Billion	0.01x	0.13x
2020	$1.20 Billion	$59.76 Billion	$8.98 Billion	0.02x	0.13x
2021	$970.79 Million	$60.99 Billion	$8.36 Billion	0.02x	0.12x
2022	$630.24 Million	$61.30 Billion	$4.14 Billion	0.01x	0.15x
2023	$927.40 Million	$62.82 Billion	-$610.00 Million	0.01x	N/A
2024	$1.89 Billion	$67.03 Billion	$771.00 Million	0.03x	2.46x
2025	$1.84 Billion	$72.34 Billion	$8.39 Billion	0.03x	0.22x

Competitor Companies of JUBLPHARMA by Market Capitalization

Companies near Jubilant Pharmova Limited in the global market cap rankings as of May 2, 2026.

Key companies related to Jubilant Pharmova Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.09

Jubilant Pharmova Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Jubilant Pharmova Limited's market cap moved from $564.62 Million to $ 1.59 Billion, with a yearly change of 10.88%.

Year	Market Cap	Change (%)
2026	Rs1.59 Billion	-13.67%
2025	Rs1.84 Billion	-2.89%
2024	Rs1.89 Billion	+104.11%
2023	Rs927.40 Million	+47.15%
2022	Rs630.24 Million	-35.08%
2021	Rs970.79 Million	-19.19%
2020	Rs1.20 Billion	+58.70%
2019	Rs756.99 Million	-23.45%
2018	Rs988.90 Million	-9.52%
2017	Rs1.09 Billion	+26.24%
2016	Rs865.76 Million	+53.33%
2015	Rs564.62 Million	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Jubilant Pharmova Limited was reported to be:

Source	Market Cap
Yahoo Finance	$1.59 Billion USD
MoneyControl	$1.59 Billion USD
MarketWatch	$1.59 Billion USD
marketcap.company	$1.59 Billion USD
Reuters	$1.59 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

Rs146.75 Billion INR

Market Cap Rank

#7149 Global

#326 in India

Share Price

Rs926.60

Change (1 day)

-0.03%

52-Week Range

Rs807.65 - Rs1236.30

All Time High

Rs1269.00